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Neuromodulators such as acetylcholine, serotonin,
and noradrenaline are powerful regulators of neocor-
tical activity. Although it is well established that cor-
tical inhibition is the target of thesemodulations, little
is known about their effects on GABA release from
specific interneuron types. This knowledge is neces-
sary to gain a mechanistic understanding of the ac-
tions of neuromodulators because different interneu-
ron classes control specific aspects of excitatory cell
function. Here, we report that GABA release from
fast-spiking (FS) cells, the most prevalent interneu-
ron subtype in neocortex, is robustly inhibited follow-
ing activation of muscarinic, serotonin, adenosine,
and GABAB receptors—an effect that regulates FS
cell control of excitatory neuron firing. The potent
muscarinic inhibition of GABA release from FS cells
suppresses thalamocortical feedforward inhibition.
This is supplemented by the muscarinic-mediated
depolarization of thalamo-recipient excitatory neu-
rons and the nicotinic enhancement of thalamic input
onto these neurons to promote thalamocortical exci-
tation.
INTRODUCTION
The neocortex is the target of extensive ascending projections
releasing neurotransmitters such as acetylcholine (ACh), sero-
tonin (5-HT, or 5-hydroxytryptamine), dopamine, and noradren-
aline and is exposed to activity-dependent levels of substances
such as adenosine and GABA. These and other neuromodula-
tors have a profound influence on the function of the cerebral
cortex due to their effects on the excitability and synaptic prop-
erties of neocortical neurons. Moreover, these modulatory sys-
tems are frequent therapeutic targets for the treatment of such
conditions as anxiety disorders, depression, schizophrenia,
and Alzheimer’s disease (Gordon and Hen, 2004; Gray and
Roth, 2007; Kasa et al., 1997; McCormick, 1993). Therefore,
understanding the cellular mechanisms of action of these
neuromodulators is exceedingly important. In cortical struc-tures, this is a challenging task due to the diversity of cellular
elements.
Inhibitory neocortical interneurons (INs) releasing the neuro-
transmitter g-aminobutyric acid (GABA) are a major target of
these modulators (Bacci et al., 2005; Beaulieu and Somogyi,
1991; Smiley and Goldman-Rakic, 1996). Although GABAergic
INs are a minority of the neuronal population of the neocortex
(10%–20%), they have profuse local axonal arborizations such
that a single GABAergic IN can control hundreds, if not thou-
sands, of excitatory cells. Interneurons have key roles in regulat-
ing the organization, function, and dynamics of cortical circuits
(Buzsaki et al., 2004; Freund and Katona, 2007; McBain and Fi-
sahn, 2001) and are believed to be involved in the pathophysiol-
ogy of neuropsychiatric disorders such as epilepsy, autism,
depression, and schizophrenia (Cossart et al., 2005; Gray and
Roth, 2007; Levitt et al., 2004). However, cortical INs constitute
a highly diverse group of neurons, with subtypes controlling spe-
cific aspects of excitatory cell function (Buzsaki et al., 2004;
Freund and Katona, 2007; Kawaguchi and Kubota, 1997; Mark-
ram et al., 2004). Knowledge of the effects of neuromodulators
on specific interneuron subtypes is very incomplete but is neces-
sary to understand how the effects of these neuromodulators on
inhibitory processes contribute to their effects on cortical net-
works and behavior.
Of particular interest are the effects of neuromodulators on
fast-spiking (FS) basket cells, the predominant IN subtype in
the mammalian neocortex. FS cell axons preferentially target
the soma and proximal dendrites of principal neurons, forming
multiple powerful synapses with a high probability of release
(Freund and Katona, 2007; Kawaguchi and Kubota, 1997; Mark-
ram et al., 2004). Consequently, and given the prevalence of FS
cells among GABAergic interneurons, GABA release from FS
cells likely constitutes the dominant inhibitory system in neocor-
tex. Although inhibition fromdendritic-targeting interneurons can
control the efficacy and plasticity of excitatory inputs onto PCs,
perisomatic inhibition is ideally suited to control the output and
synchronization of excitatory neurons, (Bartos et al., 2007;
Freund and Katona, 2007).
Several studies have found that, in contrast to other types of
INs, the excitability of FS cells is affected little, if at all, by neuro-
modulators, leading to the view that these cells tend to operate
as a near constant ‘‘clockwork’’ for cortical network oscillations
(reviewed in Freund and Katona, 2007). However, in addition toNeuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 911
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Modulation of Perisomatic InhibitionFigure 1. Presynaptic Modulation of Evoked IPSCs by Local Activation of mAChRs
(A1) Recording from an L5 PC: 1, patch pipette; 2, puffing pipette; 3, shadow from bipolar concentric stimulation electrode with 125 mm tip diameter. (A2) Pho-
tomicrograph of a 300 mm thick coronal slice of the rat somatosensory cortex with recording electrode positioned in L5a and electrical stimulation electrode
placed laterally in L5. Dotted lines indicate borders between layers. (1–3 as in [A1]).
(B1) Paired-pulse stimulating protocol used for studyingmodulatory effects of locally applied compounds. (B2) eIPSCs recorded from L5 PCs and their modulation
by locally puffedmuscarine, averaged over the timewindows denoted as 1, 2, and 3 in (C). Experiments were performed in the presence of AMPA/NMDA receptor
blockers to isolate inhibitory synaptic transmission.
(C) Time course of changes in normalized eIPSC amplitude to first (black symbols) and second (gray symbols) stimuli produced bymuscarine puff (data averaged
from five experiments).
(D) Population data from all experiments (n = 20), representing the changes in normalizedmean amplitude of first IPSC and paired-pulse ratio (PPR) in control (gray
column) and during muscarine puff (white column).
(E) Currents evoked by a brief (1 ms) local application of GABA (100 mM) to an L5 PC in control (left panel) and in the presence of a bath-applied muscarine (right
panel). Traces are averages of ten trials. Summary graphs show mean ± SEM, *p < 0.01, paired t test. Ctx, cortex; Str, striatum.their presence in somatodendritic membranes, receptors for
many neuromodulators are also present in presynaptic terminals
where they can powerfully regulate neurotransmitter release. In
prefrontal cortex, GABA release from synaptic terminals of FS
cells is regulated by dopamine (Gao et al., 2003); however, the
effects on FS cell terminals of other neuromodulators that have
widely distributed receptors in neocortex have not been investi-
gated.
In this study, we investigated the modulation of GABA release
from FS INs in somatosensory cortex. We first screened for
agents that modulate the inhibitory postsynaptic currents
(IPSCs) evoked in L5 pyramidal cells (PCs) by extracellular stim-
ulation using an assay biased toward detecting modulation
of GABA release from FS cells. Four out of ten agents tested
were found to effectively inhibit eIPSC amplitude via presynaptic
mechanisms: muscarine, serotonin, adenosine, and baclofen.
We then used paired recordings from synaptically connected
FS-to-PC pairs to confirm that the modulations occur at FS
cell synapses. The results of activation of muscarinic receptors
were particularly strong, and experiments in thalamocortical
(TC) slices showed powerful suppression of feedforward inhibi-
tion and, as a result, regulation of the window of integration
and summation of thalamic inputs and hence the dynamics of
the thalamocortical circuit. The effect on feedforward inhibition912 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.is complemented by a muscarinic-mediated depolarization of
thalamo-recipient excitatory neurons and a nicotinic-mediated
enhancement of TC EPSPs on excitatory (but not inhibitory)
neurons to facilitate TC excitation of the cortex.
RESULTS
Screening for Modulators of Perisomatic Inhibition
of Neocortical Pyramidal Cells
To screen for modulators of GABA release from FS cells, we re-
corded the IPSCs evoked by extracellular stimulation (eIPSCs) in
L5 PCs of somatosensory cortex using a paired-pulse stimula-
tion protocol (Figures 1A and 1B1). IPSCs were recorded in
the presence of inhibitors of glutamatergic neurotransmission.
eIPSCs reversed near ECl and were blocked by GABAA receptor
antagonists. At interpulse intervals ranging from 20 to 500 ms,
paired-pulse depression was always observed, with an average
paired-pulse ratio (PPR, calculated as mean IPSC2/mean IPSC1)
of 0.84 ± 0.04 (n = 165) for the 20 Hz stimulation used in most ex-
periments. Pharmacological agents were applied directly onto
the soma of the recorded cell using fast local puffs through a sec-
ond patch pipette located 5–10 mm away from the PC soma
(Figure 1A). This restricted drug action to an 50 mm radius
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t.from the puffing pipette tip (see Figure S1 available online), there-
fore sampling effects on perisomatic inputs.
We used this experimental paradigm to screen several neuro-
modulators known to activate signaling pathways following as-
sociation with G protein-coupled receptors (GPCRs). We found
that the majority of the agents (6 out of 10) had no detectable
effect on the eIPSCs (Table 1). However, four of the compounds,
muscarine, adenosine, serotonin, and baclofen, produced con-
sistent effects on the eIPSCs, suggesting robust modulation of
inhibitory synaptic transmission.
Locally applied muscarine (1–20 mM), an agonist of muscarinic
acetylcholine receptors (mAChRs), produced a robust and re-
versible reduction of eIPSC amplitude in 24 out of 24 cells tested
(Figures 1B and 1C). On average, 10 mMmuscarine inhibited the
amplitude of eIPSCs by 62% ± 8% (Figure 1D; range 45%–86%,
p < 0.001, paired t test, n = 20). This effect ofmuscarine is likely of
presynaptic origin because muscarine did not produce changes
in the rates of rise and decay of the eIPSCs or the input resis-
tance (Rin) of the postsynaptic cell. Moreover, inhibition of the
IPSC by muscarine was accompanied by an increase in the
PPR (Figure 1D). In addition, muscarine had no effect on the cur-
rents elicited in PCs by brief local application of GABA (p > 0.8,
n = 5, Figure 1E).
Serotonin and adenosine produced smaller but consistent ef-
fects on the eIPSCs. Local application of serotonin (1–10 mM)
produced a reversible inhibition of eIPSCs in 16 out of 20 cells
tested (Figure 2A). On average 10 mM serotonin inhibited the
amplitude of eIPSCs by 27% ± 6% (Figure 2D, range 19%–
35%, p < 0.001 paired t test, n = 13). Increasing the serotonin
concentration 5-fold to 50 mM did not produce additional inhibi-
tion. Adenosine (10–50 mM) produced a reversible inhibition of
the eIPSCs in 10 out of 10 cells tested (Figure 2B), with an av-
erage reduction of eIPSC amplitude of 39% ± 6% for 50 mM
(Figures 2B and 2D, range 29%–55%, p < 0.0001 paired t
test, n = 7). The effects of adenosine and serotonin on the am-
plitude of the eIPSCs were also of presynaptic origin because
there were no changes in the kinetics of the eIPSCs, the Rin
of the postsynaptic cell, or the currents elicited by local applica-
tion of GABA (p > 0.9, n = 5 in each case, Figures 2A and 2B),
and both resulted in an increase in the PPR (Figure 2E). Activa-
tion of GABAB receptors by local application of baclofen (1–10
mM) potently and reversibly inhibited the amplitude of eIPSCs in
10 out of 10 cells tested (Figure 2C), with 10 mM producing an
average reduction of the eIPSCs of 75% ± 5% (Figures 2C
and 2D, range 55%–91%, p < 0.0001 paired t test, n = 7). As
in the case of the previous modulators, baclofen did not change
the rates of rise and decay of the eIPSCs or the Rin of the post-
synaptic cell and produced an increase in the PPR (Figure 2E).
Furthermore, baclofen application did not affect the amplitude
of the currents elicited by local application of GABA onto the
PC (p > 0.9, n = 5, Figure 2C), indicating a presynaptic mecha-
nism of action. The effect of baclofen was prevented by preap-
plication of the specific GABAB receptor antagonist CGP55845
(Figure S2B).
It is known that muscarine can depolarize a subtype of so-
matostatin-containing INs known as LTS cells (but not FS cells,
see below), which could lead to an increase in cortical GABA
concentration (Beierlein et al., 2000). Elevated GABA couldNeuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 913
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Modulation of Perisomatic Inhibitioninhibit GABA release from the INs responsible for the eIPSC by
activating presynaptic GABAB receptors. However, the GABAB
receptor blocker CGP55845 did not affect the action of musca-
rine on the eIPSC (Figure S2A).
It should be noted that the aforementioned recordings from
PCs were made with a Cs+-based intracellular solution that ef-
fectively blocks many K+ channels, such as G protein-activated
inward rectifier K+ channels (GIRKs), that otherwise might be
targets of the modulators investigated here. The effects of mus-
carine and baclofen in cells recorded with physiological intracel-
lular solutions are described later.
FS Basket Cells Are the Major Contributors to the eIPSC
We reasoned that the assay we used in the previous experiments
is biased toward detecting effects of modulators on the eIPSC
resulting from GABA release from FS INs based on the following
arguments.
First, although the axons of many interneuron types are stim-
ulated with an extracellular electrode, most of the eIPSC in L5
PCs is likely to arise from FS cells because they are the largest
(50%) population of INs in L5 and, given the perisomatic local-
ization of their terminals, should produce larger somatically re-
corded IPSCs (Kawaguchi and Kubota, 1997; Markram et al.,
2004). To explore this quantitatively, we compared the proper-
ties of unitary synaptic connections onto L5 PCs from identified
FS basket cells and the second largest (30%–40%) class of L5
INs, the somatostatin-positive Martinotti cells (MCs) (Figure 3;
Kawaguchi and Kubota, 1997; Markram et al., 2004). The
strength of the unitary synaptic connections measured at the
PC soma was about 10-fold smaller for MC-to-PC pairs com-
pared to FS-to-PC pairs (13 ± 5.4 pA versus 129 ± 24 pA,
Figure 2. Presynaptic Modulation of eIPSCs
by Local Activation of 5-HT, Adenosine, and
GABAB Receptors
(A) Serotonin modulation of eIPSCs. (Left panel)
eIPSCs recorded from L5 PCs and their modula-
tion by locally puffed serotonin, averaged over
the time windows denoted as 1, 2, and 3 in the
middle panel. (Middle panel) Time course of
changes in normalized first and second eIPSC am-
plitude in response to serotonin puff (data aver-
aged from five experiments). (Right panel) Effect
of serotonin on currents induced by GABA puff.
(B and C) Same as (A), but for the effect of adeno-
sine and baclofen, respectively.
(D) Population data describing the effect of seroto-
nin (n = 13), adenosine (n = 7), and baclofen (n = 7)
on the amplitude of eIPSCs.
(E) Changes in paired-pulse ratios produced by
the above-mentioned compounds. Summary
graphs show mean ± SEM; *p < 0.01; **p <
0.001, paired t test.
p = 0.0004, Mann-Whitney U test). More-
over, the synaptic delay and the latency
to peak of the unitary IPSCs (uIPSCs)
were much longer and less synchronous
in MC-to-PC versus FS-to-PC pairs
(Figure 3D). These observations suggest
a minor contribution of MCs to the peak amplitude of the eIPSC
measured in L5 PC somata. Furthermore, the peak of somatically
recorded uIPSC from MCs occurs after the peak of the eIPSC
(4.46 ± 0.3 versus 2.6 ± 0.5 ms, n = 10).
Second, it has been shown in the hippocampus that FS cells
utilize P/Q-type Ca2+ channels for synaptic transmission, while
other interneurons making synapses near the soma of pyramidal
cells utilize N-type Ca2+ channels (Hefft and Jonas, 2005; Wilson
et al., 2001). We investigated whether FS cells in barrel cortex
also utilize exclusively P/Q-type Ca2+ channels for synaptic
transmission. As illustrated in Figure S3, unitary FS-PC connec-
tions in L5 barrel cortex were insensitive to bath application
of the Cav2.2 (N-type) Ca
2+ channel blocker u-conotoxin-GVIa
(1 mM) but were completely and irreversibly blocked by the
Cav2.1 (P/Q-type) Ca
2+ channel antagonist u-agatoxin-IVa
(500 nM). We then tested the effect of blocking N- or P/Q-type
Ca2+ channels on the eIPSCs. BlockingN-type Ca2+ channels re-
duced the amplitude of eIPSCs by 15% ± 4% (Figure 3E, n = 5,
p < 0.01, paired t test). In contrast, blocking P/Q-type Ca2+ chan-
nels dramatically reduced the amplitude of the eIPSCs by 89%±
5% (Figure 3E, n = 3, p < 0.001, Wilcoxon test). Interestingly, the
component of the eIPSC remaining after blocking P/Q-type Ca2+
channels displayed facilitating short-term dynamics, instead of
the depression seen for the total eIPSC (Figure 3F). Hence, the
contribution of the N-type Ca2+ channel-dependent eIPSC to
the first total eIPSC of the train is about 10%; however, it rises
during repetitive stimulation reaching 30% at the fifth stimulus
at 50 Hz. This component also showed fast kinetics of rise and
decay (Figure 3F), suggesting it does not arise from Martinotti
cells, but from a population of non-FS interneurons that form
proximal synapses on the PC. This component could arise914 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.
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Modulation of Perisomatic InhibitionFigure 3. FS Basket Cells Mediate Most of the eIPSC in L5 PCs
(A–D) Properties of unitary synaptic connection of FS and Martinotti cells onto L5 PCs. (A) Representative high-frequency nonaccommodating firing pattern of
a L5 FS cell. (Lower panel) Depressing uIPSCs in a PC produced by stimulation of an FS cell with five brief current injections (0.5 nA, 2 ms) at 50 Hz (ratio between
fifth and first IPSC = 0.25 ± 0.05, Rin(FS) = 89 ± 15 MU, tmembr(FS) = 9.2 ± 1.5 ms, n = 8). (B) Representative firing pattern of an L5 MC, showing low spike threshold
and rebound spikes. (Lower panel) Facilitating uIPSCs in an L5 PC produced by stimulation of an MC at 50 Hz (IPSC5/IPSC1 = 0.91 ± 0.07, Rin(MC) = 241 ± 55 MU,
tmembr(MC) = 19.2 ± 3.5 ms, n = 5). (C) Morphological reconstruction of a connected MC-to-PC pair, blue dots indicate putative synaptic contacts between MC
axon (red) and PC dendrite (blue). Dendrites of MC shown in green, the axon of PC in gray. (D) (Left) Quartile plot of uIPSCs amplitudes at 30C. The central dot is
the mean, the central line is the median value, the box edges mark the interquartiles, and the bars mark the limits of the sample distribution. (Center, right) Dis-
tribution histograms of synaptic delay and the latency to the peak of uIPSCs measured relative to the peak of presynaptic action potential. The data were pooled
from five connected pairs (ten trials each). *p < 0.001 Mann-Whitney U test.
(E and F) Ca2+ channels mediating extracellularly evoked GABA release. (E) (Right) Representative example showing modest inhibition of eIPSCs in L5 PC by N-
type Ca2+ channel blocker and lack effect of this treatment on the baclofen-induced reduction of eIPSCs. (Left) Blocking P/Q-type Ca2+ channels dramatically
inhibits eIPSCs and suppresses the effect of baclofen. (F) P/Q-type Ca2+ channel blocker insensitive component of the eIPSC shows facilitating profile (top) as
well as fast kinetics of rise and decay similar to total eIPSC (bottom). Black traces, control; blue, after u-Aga-Tx-IVa.from CCK basket cells, which display facilitating synapses (Gal-
arreta et al., 2004) or other non-FS cells making proximal con-
nections on the pyramidal cell. Next, we explored the effects of
the neuromodulators on the eIPSCs in the presence of the Ca2+
channel blockers. We found that the N-type Ca2+ channel
blocker did not affect the magnitude of the baclofen-induced
inhibition of eIPSCs (Figure 3E, 71% ± 6% versus 75% ±
5%, n = 3, p > 0.8, Wilcoxon test) or the magnitude of the mus-
carine effect (51% ± 7% versus 55% ± 8%, n = 2, data notshown), further suggesting that their actions occur on FS cell
terminals.
Third, we found that local somatic application of low doses (1
mM) of tetraethylammonium (TEA), which blocks Kv3 potassium
channels in FS cell terminals, increased the amplitude of eIPSCs
by a factor of 1.88 ± 0.11 (range 1.58–2.01, n = 8) without affect-
ing the shape of the IPSC (Figure S4). The magnitude of the
observed effect of TEA is similar to that reported for the effect
of 1 mM bath-applied TEA on the unitary IPSC in FS-to-PCNeuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 915
Neuron
Modulation of Perisomatic InhibitionFigure 4. Modulation of FS-to-PC Connec-
tions
(A) (Left) Inhibition of uIPSCs triggered by brief cur-
rent injections delivered to a L5 FS cell (0.5 nA,
2 ms at 20 Hz) and recorded in a nearby PC by
bath application of muscarine (10 mM). Responses
shown are the average of ten sweeps. (Right) Pop-
ulation data showing normalized mean amplitude
of first IPSC, paired-pulse ratio, and coefficient
of variation in control (filled column) and during
muscarine application (white column).
(B–D) same as in (A), but for serotonin (10 mM),
adenosine (50 mM), and baclofen (10 mM), respec-
tively. Summary graphs show mean ± SEM; *p <
0.01 paired t test.connections (1.62 ± 0.25; Goldberg et al., 2005), further support-
ing the contention that the majority of the eIPSCs on L5 PCs
arises from FS cells. Finally, as shown below, all four neuromo-
dulators that affected the eIPSC had quantitatively similar
effects on unitary FS-to-PC connections.
Modulation of Unitary FS-to-PC Synaptic Transmission
To confirm that GABA release from FS cell synapses is regulated
by the four neuromodulators affecting the eIPSC, we performed
dual whole-cell recordings from connected FS-to-PC pairs in L5.
We found that bath-applied serotonin, muscarine, adenosine,
and baclofen inhibited the amplitude of the uIPSC to a similar ex-
tent as the eIPSC (Figure 4, n = 5 in each case, p < 0.01, paired t
test), without affecting uIPSC kinetics. We also monitored the
PPR and the coefficient of variation (CV) of uIPSC amplitudes.
While changes in CV do not unequivocally reflect a presynaptic
mechanism, these two parameters are widely used to evaluate
changes in neurotransmitter release probability (Zucker and Re-
gehr, 2002). We found that all four reagents increased the PPR
and the CV of uIPSCs (Figure 4, p < 0.01, paired t test), support-
ing a presynaptic mechanism of action.
The experiments described so far were carried out in infragra-
nular layers. We asked whether the two most potent modulators
of GABA release from FS cells in these layers—muscarine and
baclofen—would exhibit the same effect in supragranular layers.
As shown in Figure S5, muscarine and baclofen inhibited unitary
synaptic transmission from FS-to-L3 PCs similarly to their action
in infragranular layers, suggesting that the modulation of periso-
matic GABA release occurs in FS cells throughout somatosen-
sory cortex.
Two Pathways for the Modulation of GABA Release
Observation of the time course of drug action on the eIPSC sug-
gested that the effect of serotonin was slower than the effects of
muscarine, adenosine, or baclofen (Figures 1 and 2). However,
the stimulation frequency (0.1 Hz) used in those experiments
did not provide sufficient resolution to accurately measure the
rates of the modulatory effects. Therefore, we increased the
time resolution of our assay by stimulating at 0.5 Hz while916 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.decreasing the extracellular Ca2+ concentration to 1.3 mM
(Figure 5). Reducing extracellular Ca2+ was necessary to lower
the release probability andminimize short-term synaptic depres-
sion at these rates of stimulation.We found that the effect of local
application of serotonin developed after a 6.5 ± 0.9 s delay, and
the time course of the modulation, fitted with the logistic Hill
function, yielded a time constant of 17.5 ± 4.2 s (n = 5, r2 = 0.85).
On the other hand, the effects of muscarine, adenosine, and ba-
clofen showed no delay, and their time constants were 7 ± 2.0 s
(n = 5, r2 = 0.89), 8 ± 3.1 s (n = 5, r2 = 0.94), and 6 ± 3.9 s (n = 5, r2 =
0.96), respectively. Such a ‘‘slow’’ and ‘‘fast’’ time course of
eIPSC inhibition suggests that two different mechanisms of
modulation are involved.
To explore this conclusion further, we asked whether protein
phosphorylation is required for the effects of each modulator.
We incubated the slices for 2 hr with staurosporine (1 mM), a pro-
tein kinase (PK) inhibitor able to block many PKs (PKA = PKC >
PKG > CaMK) (Hidaka and Kobayashi, 1993). We found that
the effect of serotonin on the eIPSC was the only modulation af-
fected by staurosporine (2%± 4.0% inhibition of the eIPSC in the
presence of staurosporine versus 27% ± 6% inhibition in control
slices, Figures 5C and 5D, n = 10, p < 0.01, unpaired t test). The
inhibitory effects of muscarine, adenosine, and baclofen were
not affected by the treatment with staurosporine (Figures 5C
and 5D, p > 0.5, unpaired t test). This suggests that the ‘‘slow’’
modulation observed with serotonin involves a PK-dependent
second messenger pathway, while the ‘‘fast’’ modulations pro-
duced by muscarine, baclofen, and adenosine are independent
of PK activity and likely involve the membrane-delimited in-
hibition of presynaptic Ca2+ channels (Hille, 2001; however, see
Discussion).
These two types of signaling mechanisms are mediated by
distinct G proteins activated by specific receptor subtypes.
The membrane-delimited modulation typically requires associa-
tion of the target molecules, such as the a1 subunit of neuronal
Ca2+ channels, with the bg subunits of pertussis toxin-sensitive
Gi/o protein (Dolphin, 2003; Mirotznik et al., 2000). While it is
known that adenosine A1 receptors and GABAB receptors are
coupled to Gi/o proteins (Wettschureck and Offermanns, 2005),
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(A) A protocol used for studying the time course of modulation. Note reduced extracellular [Ca2+].
(B) ‘‘Slow’’ and delayed modulation of eIPSCs amplitude by locally applied serotonin and ‘‘fast’’ eIPSC modulation by local application of muscarine, adenosine,
and baclofen. eIPSCs were normalized and averaged from five experiments. The datasets were fitted with the logistic Hill function, with ‘‘zero’’ time at the be-
ginning of drug application. The time constants of the fit are shown in red.
(C and D) ‘‘Slow’’ but not ‘‘fast’’ modulation requires activation of protein kinases. (C) Representative example (top left) demonstrating the absence of serotonin
effect on eIPSCs amplitude after preincubation of slice with staurosporine for 2 hr. (Other panels) Examples of staurosporine inability to preclude the effects of
muscarine, adenosine, and baclofen. Drug concentrations are the same as in (B). (D) Population data comparing drug effects with (gray columns) or without (white
columns) staurosporine preincubation. Shown are means ± SEM; *p < 0.01, unpaired t test.the large molecular diversity of serotonin and muscarine recep-
tors requires further analysis to determine the receptor type
that mediates the modulation of GABA release.
Pharmacological studies presented in supplementary material
(Figures S6 and S7) suggest that the effect of serotonin on the
eIPSC is mediated by 5-HT2 receptors. These receptors are cou-
pled to Gq/11 protein that activates the PLC pathway and subse-
quently PKC (Wettschureck and Offermanns, 2005), supporting
the hypothesis that PK activity mediates the action of serotonin
on IPSCs. On the other hand, the effect of muscarine appears
to be mediated by M2 and M4 receptors, which are coupled to
Gi/o proteins, supporting the conclusion that the muscarinic
effect on eIPSCs involves the membrane-delimited pathway.
Modulation of GABA Release from FS Cells
and the Control of Excitatory Cell Activity
We showed that four neuromodulators robustly inhibit GABA re-
lease from FS cells—muscarine and baclofen being particularly
effective. The significance of this reduction in perisomatic inhibi-
tionwas tested by investigating howmuscarine affects the ability
of FS cells to control the activity of neocortical PCs (Figure 6).
These experiments used intracellular Cl– concentrations to
match the physiological Cl– reversal potential (–70mV; Cossart
et al., 2005). Layer 3 PCs were depolarized to produce sustained
action potential (AP) discharge at a rate of5 Hz, by a 30 pA cur-rent injection. A train of APs (30 spikes at 40Hz) evoked in a single
connected FS cell was able to dramatically reduce the firing
probability of the PC (by 75% ± 7%, p < 0.01, n = 4, Wilcoxon
test). Bath application of 10 mMmuscarine significantly reduced
the IPSPs recorded in the postsynaptic PC (Figure 6A, inset) and
as a result prevented the GABA-mediated silencing of PC firing
(Figures 6A and 6C). We also investigated how modulators
change the effect of perisomatic inhibition on the discharge of
PCs evoked by afferent stimulation. Strong stimulation of white
matter (Figure 6B, inset) was required to drive deep L3 PCs to fir-
ing threshold. Spike probability was severely reduced (by 93% ±
5%, p < 0.01, n = 4, Wilcoxon test, Figures 6B and 6C) by a few
APs evoked in a single connected FS IN. Bath application of
muscarine significantly relieved the inhibitory control of PC dis-
charge imposed by the FS IN (31% ± 7% versus 93%± 5% firing
suppression, p < 0.01 Wilcoxon test, Figures 6B and 6C).
Modulation of Thalamocortical Integration
The robust inhibition by muscarine of GABA release from neo-
cortical FS cells suggests that this modulation might contribute
to mediating the powerful actions of ACh on cortical function.
To investigate the physiological significance of this modulation,
we studied a neocortical circuit in which synaptic transmission
from FS cells has a well-defined role. It is known that individual
thalamocortical (TC) afferents contact both excitatory neuronsNeuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 917
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Modulation of Perisomatic InhibitionFigure 6. Modulation of the Inhibitory Control of PC Activity
(A) Representative recording from a connected pair of an L3 PC and an FS IN. (Top) An overlay of 15 sweeps recorded from the PC following injection of 30 pA
depolarizing current (4 s). A train of 30 APs at 40 Hz in the connected FS IN (bottom) silenced PC firing. Bath application of muscarine relieved the silencing of the
PC (middle panel). (Inset) Muscarine-induced reduction in uIPSPs (scale bar = 1.5 mV/150 ms, Vm(PC) = 55 mV, ECl– = 70 mV).
(B) Same as in (A), but APs in the PC (Vm =60 mV) were evoked by white matter (w.m.) stimulation (inset). Five APs in FS IN preceding w.m. stimulation (bottom)
reliably suppressed AP generation in PC (top). Bath application of muscarine prevented FS cell-mediated suppression of PC firing (middle).
(C) Probability of PC firing calculated as the ratio of number of APs in PC during FS IN firing relative to this number in the absence of FS IN stimulation (black bar).
The same ratio in the presence of muscarine (blue bar). *p < 0.01, n = 4, Wilcoxon test. Shown are means ± SEM.and FS interneurons in L4 and deep L3. Activation of both excit-
atory and inhibitory cells establishes a simple disynaptic circuit
that provides powerful, local feedforward inhibition (Figures 7A
and 8F). The latency between the onset of the TC excitation of
excitatory cells and the onset of feedforward inhibition results
in a temporal integration window (IW) during which the excitatory
neurons can integrate TC inputs. This window is critical for the
processing of sensory information in the neocortex (Cruikshank
et al., 2007; Gabernet et al., 2005; Miller et al., 2001; Swadlow,
2003; Wilent and Contreras, 2004, 2005).
We recorded sequences of excitatory/inhibitory postsynaptic
events from deep L3/L4 excitatory cells (ECs) evoked by stimu-
lation of the ventrobasal (VB) nucleus of the thalamus in the tha-
lamocortical slice preparation and studied the effect of musca-
rine on the apparent IW measured as the duration of the net
inward current in EPSC/IPSC sequences (Figures 7B and 7C).
Local muscarine application significantly decreased the disy-
naptic inhibitory response and consequently increased the
apparent IW by 55% ± 6% (Figures 7B and 7C; n = 6, p = 0.017,
Wilcoxon test).
The effect of muscarine was not due to failure in the firing of FS
cells in response to TC stimulation, becausewe could clearly dis-
tinguish such failures by the absence of the outward (inhibitory)
component in EPSC/IPSC sequences (see, for example, the
two lower traces in the middle panel in Figure 7B, and note the
absence of the notch produced by the onset of disynaptic
IPSC). Failures occurred occasionally in the presence or ab-
sence of muscarine, but on average, we did not observe a mus-
carine-induced increase in failure rate of FS IN firing in response
to TC stimulation (p > 0.8, n = 6; failure rates were 15% ± 6% in
absence and 18% ± 7% in presence of muscarine). This stands
in contrast to the effects of activation of GABAB receptors on TC
responses. Application of baclofen (10 mM), which produces po-
tent inhibition of GABA release from FS cells, also prolonged the918 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.apparent IW (n = 3, Figure 7D). However, in this case there was
a complete elimination of the inhibitory component of the TC re-
sponse, as can be appreciated by the lack of an outward current
in the presence of baclofen (Figure 7D). Therefore, the action of
this drug on the IW seems to result primarily from an inhibitory
effect on the TC-to-FS IN connection that prevents FS cell
from firing (see below).
To appreciate the effects of the muscarinic modulation of TC
responses on the integrative properties of excitatory thalamo-re-
cipient cells, we investigated how simulated EPSPs (sim-EPSPs)
summate with the TC-evoked disynaptic EPSP/IPSP sequence
(Figure 7E). Individual EPSPs on thalamo-recipient ECs are
small, and hence EPSP summation is necessary to excite these
cells and initiate cortical excitation (Cruikshank et al., 2007). sim-
EPSPs were generated in ECs by injecting prerecorded TC
EPSCs in current-clamp mode. We found that summation of
sim-EPSPs with the TC response depended on the timing of
TC EPSC injection. There is a narrow IW (range 1–2 ms, n = 4)
during which sim-EPSP can effectively summate with the TC re-
sponse, followed by a refractory period with a pronounced sub-
linear summation (13 ± 0.8 ms required for 90% recovery, n = 4,
Figures 7E and 7F), likely explained by the potent shunt pro-
duced by perisomatic GABA release (Gabernet et al., 2005). Lo-
cal application of muscarine significantly increased the summa-
tion efficacy during the initial IW (113% ± 8% versus 84% ± 6%,
n = 4, p = 0.027,Wilcoxon test) and decreased the duration of the
refractory period (Figures 7E and 7F; 9 ± 0.6 ms required for 90%
recovery, n = 4), likely a result of the muscarinic reduction of the
GABA-mediated shunt (Figure 7E, right inset).
We next investigated the effects of neuromodulators on the
other elements of the feedforward thalamocortical circuit (see
summary diagram in Figure 8F) in order to appreciate how the
observed effects on feedforward inhibition may combine with
other effects to modulate thalamic excitation of the cortex. We
Neuron
Modulation of Perisomatic InhibitionFigure 7. Neuromodulators Regulate Thalamocortical Feedforward Inhibition and Integration
(A) A cartoon of TC slice preparation depicting the schematics of the feedforward inhibitory circuit and the recording arrangement.
(B) Overlay of 15 EPSC/IPSC sequences (Vh = 45 mV) before, during, and after local perfusion of muscarine (10 mM). Bold line is the average of the currents
(excluding failures) under each condition. The ‘‘window of integration’’ is denoted as IW (see text).
(C) Population data representing muscarine effect on IW (n = 6). Shown are means ± SEM.
(D) Application of baclofen (10 mM) eliminates the outward feedforward inhibitory component of EPSC/IPSC sequence and strongly inhibits the excitatory com-
ponent (traces are averages of ten sweeps).
(E) Ten superimposed EPSP/IPSP sequences (L3/4 EC, Vm =45mV)with sim-EPSPs triggered at different intervals (at 1, 3, 5, and then every 4ms) after thalamic
stimulation, with (right) and without (left) local application of muscarine. Bold line is the average of 15 EPSP/IPSP sequences without sim-EPSCs injection (shown
superimposed in the top-right inset). (Bottom) Time course of sim-EPSC injection.
(F) Summation of thalamic response and sim-EPSPs calculated as the ratio of the value of the response minus the value of averaged EPSP/IPSP sequence at the
time of sim-EPSP peak (a) to the amplitude of sim-EPSP (b, top-left inset in [E]). Shown are means ± SEM; *p < 0.01, paired t test.first studied the effect of local muscarine application on the iso-
lated excitatory and inhibitory component of the EPSC/IPSC se-
quence by recording PSCs at the reversal potential for the
respective neurotransmitter current. The isolated disynaptic
inhibitory component was much more sensitive to muscarine
than the monosynaptic excitatory component (54%± 8% versus
18% ± 4% reduction, n = 4, Figures 8A and 8D). Muscarine did
not change the latency or time to peak of either the monosynap-
tic excitatory or the disynaptic inhibitory component (Figure 8A,
insets), suggesting modulation of the same synaptic connec-
tions rather than recruitment of distinct connections following
drug application.
Second, we investigated the effect of muscarine on the TC
drive to FS and excitatory cells in layers 3/4, by simultaneously
recording TC EPSPs in both cell types (Figures 8B–8D). Stimula-
tion of TC afferents produced significantly larger EPSPs in FS INs
than in ECs (7.4 ± 2.1 mV versus 2.3 ± 0.6 mV, n = 12, p < 0.01
paired t test), as previously reported (Cruikshank et al., 2007).
Bath application of muscarine shifted the balance of TC drive
by slightly inhibiting TC EPSPs on ECs, while not affecting TCEPSPs on FS INs (Figures 8B–8D). In contrast, activation of GA-
BAB receptors inhibited the TC EPSP on FS INs twice as potently
as the TC EPSP on ECs (Figures 8C and 8D, right panel, and
Figure S8). We also studied the effect of muscarine on the mem-
brane properties of FS INs and ECs. Muscarine depolarized ECs
and slightly decreased Rin; while not affecting the membrane
properties of FS INs (Figure 8E and Figure S9).
Because ACh activates both nicotinic and muscarinic recep-
tors, we also investigated the effects of nicotine on the various
components of the TC feedforward circuit. Contrary to the
effects of muscarine, 5 mM nicotine increased the amplitude of
TC EPSPs on ECs without affecting the TC drive to FS INs
(Figure S10E and Figures 8C and 8D). Furthermore, a local nico-
tine puff increased the amplitude of the excitatory component
of the excitatory-inhibitory PSC sequence in response to TC
stimulation (Figure 8D and Figure S10B), but did not affect the
disynaptic GABA release from FS cells or the apparent
IW (Figure S10C). Nicotine application did not affect the mem-
brane potential or Rin of the FS INs or the ECs (Figure 8E and
Figure S9).Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 919
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Modulation of Perisomatic InhibitionFigure 8. Modulation of Specific Compo-
nents of the Feedforward TC Circuit
(A) Electrical segregation of feedforward inhibitory
and excitatory components of the excitatory-
inhibitory sequence produced by TC stimulation
and their modulation by locally applied muscarine.
PSCs were recorded in L3 ECs held at EAMPA (0
mV, top) and ECl
– (–70 mV, bottom). Insets
show the absence of muscarine-induced changes
in the latency of each PSC.
(B) TC EPSPs simultaneously recorded in a GFP-
positive FS IN and a nearby EC in L3/4 (traces
represent the averages of ten sweeps) and their
modulation by bath application of muscarine
([inset] diagram of experimental design).
(C) Modulator-induced shift in the balance of TC
excitatory drive onto ECs and FS INs, computed
as the ratio of the amplitude of TC EPSP in EC
over TC EPSP in FS IN, both normalized to values
before drug application. Plots are the averages of
four experiments.
(D) Population data of modulator effect on post-
synaptic response, plotted relative to correspond-
ing value before drug application. TC, thalamo-
cortical; FF fedforward.
(E) Population data on change in resting mem-
brane potential of ECs and FS INs produced by
bath application of the indicated modulator.
(F) Schematic diagram summarizing effects of
neuromodulators on each component of feed-
forward TC circuit. ‘‘+’’ or ‘‘–’’ denotes potentiation
or inhibition of synaptic transmission, with the
strength of the effect indicated by the number
of symbols; arrows denote change in Vm (up
depolarization). Summary graphs show mean ±
SEM. p < 0.01, paired t test.Thus, in summary, our results show that cholinergic action fa-
cilitates thalamocortical excitation of primary somatosensory
cortex primarily by reducing feedforward inhibition. This effect
is complemented by a nicotinic-mediated increase in the TC
drive onto thalamo-recipient ECs as well as the muscarinic-me-
diated increase in the excitability of these cells (Figure 8F). In
contrast, activation of GABAB receptors inhibits all synapses in
the circuit, but most potently TC excitation of FS INs and periso-
matic GABA release, therefore effectively excluding FS cells
from generating feedforward inhibition.
DISCUSSION
In this study, we developed an assay to screen for modulators of
GABA release from FS basket cells. We found that activation of
four out of ten G protein-coupled receptors (GPCRs) tested—
muscarinic, serotonin, adenosine, and GABAB receptors—pro-
duced, via two different mechanisms, robust inhibition of periso-
matic GABA release. We confirmed that these modulations920 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.occur on terminals of FS basket cells using paired recordings
from synaptically connected FS-to-pyramidal cell pairs.
These modulators have powerful effects on the function of the
neocortex, and it is likely that the observed effects on GABA re-
lease from FS cells, the source of the dominant inhibitory system
in neocortex controlling the output of principal cells, contribute
significantly to their actions on cortical function. The effects of
muscarine, whichwere particularly strong, are of special interest,
given the importance of cholinergic modulation of cortical activ-
ity. We showed that the potent inhibition of GABA release from
FS cells produced by activation of muscarinic cholinergic recep-
tors regulated the dynamics of thalamocortical activation.
FS Basket Cells Mediate Most of the eIPSC in L5 PCs
To screen for neuromodulators of GABA release from FS cells,
we tested the effects of locally applied reagents on the somati-
cally recorded eIPSC on L5 PCs in somatosensory cortex. We
show that this assay is biased toward detecting modulation of
GABA release from FS cells based on evidence that the large
Neuron
Modulation of Perisomatic Inhibitionmajority (90%) of the eIPSC under our recording conditions is
mediated by GABA release from this class of interneurons.
Dendritically targeting Martinotti cells contribute little to the
somatically recorded eIPSC given the amplitude and timing of
their unitary currents; however, these neurons may play an im-
portant role in the local dendritic integration or be a source of
a potent recurrent inhibition following high-frequency repetitive
PC activity (Kapfer et al., 2007; Silberberg and Markram, 2007).
Another class of basket cells—CCK-positive basket cells—
also have a minor contribution to the amplitude of the eIPSC,
given their low abundance in L5 (5% of all interneurons) and
significantly fewer number of perisomatic contacts on large
PCs in L5. Moreover, CCK basket cells receive less glutamater-
gic input and are more difficult to drive than FS cells (Freund and
Katona, 2007). Consistent with this conclusion, there was no de-
tectable effect on the eIPSC upon activation of presynaptic can-
nabinoid (CB1) receptors (Table 1), which are present in a large
proportion of CCK-basket cell terminals and mediate inhibition
of neurotransmitter release (Bodor et al., 2005).
Together, our data strongly indicate that under our experimen-
tal conditions GABA release from FS basket cells constitutes the
majority of the eIPSC in L5 PCs, suggesting that FS cells are re-
sponsible for the dominant part of the inhibition converging onto
PC somata evoked by electrical stimulation of nearby cells and
axons. Monitoring eIPSC in these neurons can be used reliably
and efficiently to screen modulators of GABA release from FS
INs and to study kinetic and pharmacological properties of these
modulations without having to resort tomore complicated paired
recordings.
Mechanisms of Modulation of GABA Release
from FS Cell Terminals
Interestingly, we found that themodulations characterized in this
study appear to be mediated by two different mechanisms, al-
though all four modulators produced inhibition of GABA release.
We showed that the effect of serotonin had a relatively slow on-
set and involved the activation of protein kinases (PKs) by Gq/11
proteins coupled to 5-HT2 receptors, which are known to be
present in cortex and specifically in GABAergic PV-containing
basket interneurons (Jakab and Goldman-Rakic, 2000). Seroto-
nin binding to 5-HT2 receptors leads to the activation of phos-
pholipase C (PLC-b), an enzyme that generates two intracellular
secondmessengers: inositol (1,4,5) trisphosphate and diacylgly-
cerol. These signals in turn produce an elevation in intracellular
Ca2+ and activation of protein kinase C (PKC), respectively (Ray-
mond et al., 2001). However, the ultimate target of this pathway
in FS cell terminals is not known andmay include, among others,
activation of Ca2+-dependent K+ channels or PKC-dependent in-
hibition of P/Q-type Ca2+ channels (Raymond et al., 2001).
On the other hand, the modulation of GABA release produced
bymuscarine, adenosine, and baclofen displayed fast onset and
independence of PK activation, implicating the involvement of
membrane-delimited mechanisms. These mechanisms utilize
association of bg subunits of G proteins (Gbg) with effector tar-
gets (Hille, 2001). Known effectors of this type of modulation
include G protein-activated inwardly rectifying K+ channels
(GIRKs) as well as N- or P/Q-type voltage-gated Ca2+ channels.
It is unlikely that modulation of GIRKs is involved in the regulationof GABA release from FS cells, because these channels typically
have a postsynaptic localization in the neocortex and hippocam-
pus (Luscher et al., 1997). On the other hand, direct inhibition of
the CaV2 family of Ca
2+ channels by the Gbg subunit is a well-de-
scribed phenomenon (for review see Dolphin, 2003) and has
been implicated in the presynaptic suppression of neurotrans-
mitter release in several instances, including the endocannabi-
noid-mediated inhibition of GABA release from CCK-containing
interneurons (Wilson et al., 2001). Fast, Gbg -mediated inhibition
of CaV2 channels stems from the activation of Gi/o and not Gq/11
protein (Mirotznik et al., 2000; Wettschureck and Offermanns,
2005), the type of G protein activated by adenosine A1, GABAB,
and the M2/4 receptors identified in our study. However, we can-
not rule out the possibility that Gbg affects directly the vesicle fu-
sionmachinery, as has been recently observed in some prepara-
tions (Blackmer et al., 2005).
Cholinergic Modulation of Feedforward Inhibition
ACh is one of the most important neuromodulators in the brain,
critical for normal cognitive function. Most neocortical ACh orig-
inates from axons projecting from the nucleus basalis of Meynert
(NB). Cholinergic modulation of cortical structures is important
for multiple functions, including attention, learning, memory,
and the cortical processing of sensory information (for review
see Lucas-Meunier et al., 2003; McCormick, 1993). Impairment
of cortical cholinergic function is considered crucial to the pa-
thology of Alzheimer’s disease (Kasa et al., 1997).
ACh can regulate neuronal excitability via actions on somato-
dendritic muscarinic and nicotinic receptors as well as neuro-
transmitter release through actions on receptors present in pre-
synaptic terminals. We observed that muscarine but not nicotine
depolarized ECs in L3-4 of barrel cortex, but neither muscarine
nor nicotine affected the intrinsic properties of FS INs. These re-
sults are in agreement with a recent report showing that cholin-
ergic agonists do not affect the intrinsic excitability of FS cells in
various cortical areas and different layers (Gulledge et al., 2007).
Cholinergic regulation of transmitter release in neocortex has
received less attention. Several studies point to ACh effects on
inhibitory neurotransmission (for review see Krnjevic, 2004),
yet, to our knowledge, no studies have addressed the choliner-
gic regulation of transmitter release from perisomatically target-
ing IN subtypes in neocortex. Here, we show that muscarine is
a potent inhibitor of GABA release from FS cells in somatosen-
sory cortex in both infragranular and supragranular layers. We
found that the feedforward disynaptic inhibitory response to tha-
lamocortical stimulation is much more sensitive to mAChR acti-
vation than the monosynaptic excitatory response, resulting in
an overall increase in thalamic excitation of the neocortex.
It is believed that ACh enhances attention by increasing the in-
fluence of sensory stimuli relative to internal cortical processing
by enhancing the weight of feedforward afferent inputs while
suppressing excitatory feedback connections (Hasselmo and
Giocomo, 2006; Hsieh et al., 2000; Oldford and Castro-Alaman-
cos, 2003). The net increase in TC synaptic excitation of tha-
lamo-recipient neurons due to the muscarinic suppression of
feedforward inhibition described here should be a significant
contributor to these effects of ACh. The observed muscarinic-
mediated depolarization of excitatory thalamo-recipient neuronsNeuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc. 921
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drive these cells to firing threshold.
Moreover, reduction of perisomatic inhibition produced by ac-
tivation of M2/4 AChRs in FS cell terminals provides amechanism
for broadening stimuli tuning of cortical cells by increasing the
time window during which excitatory cells can integrate sensory
inputs, making cortical neurons sensitive to stimuli to which they
normally do not respond. This idea is supported by the observa-
tion that iontophoresis of ACh to the somatosensory cortex of
awake and drug-free animals produced an enlargement of whis-
ker receptive fields (Delacour et al., 1990). Similarly, ACh broad-
ened frequency tuning in auditory cortex (McKenna et al., 1989).
Both effects are mediated by the activation of mAChRs.
Here, we show that nicotine potentiated TC synaptic transmis-
sion onto ECs (see also Gil et al., 1997) but did not affect TC drive
onto FS INs. This intriguing observation is consistent with immu-
nohistochemical results in macaquemonkey visual cortex show-
ing that nicotinic receptors are present on TC synapses on excit-
atory but not inhibitory cells (Disney et al., 2007).
FS-mediated perisomatic inhibition of ECs was unaffected by
nicotine (Figure 8). Thus, activation of nicotinic AChRs in TC af-
ferents to ECs and somatic muscarinic receptors on the ECs
will complement the reduced muscarinic-mediated perisomatic
inhibition to enhance cortical responsiveness to sensory stimuli.
Furthermore, modulation of feedforward inhibition provides con-
trol over the temporal summation of TC inputs by changing the
duration of the integration window and refractory period. The
specific subcellular localization of AChRs—nicotinic in presyn-
aptic TC afferents contacting EC dendrites, M2 in FS basket
cell output synapses (Chaudhuri et al., 2005; Hajos et al.,
1998), and M1 in ECs (Volpicelli and Levey, 2004)—may be an
important factor in the specificity of the responses to ACh.
Modulation of GABA Release by Baclofen,
Adenosine, and Serotonin
We showed that baclofen, adenosine, and serotonin also in-
hibited perisomatic GABA release from FS cells. GABAB and
adenosine receptors are expected to mediate modulations by
agents that are predominantly intrinsic to the neocortex and reg-
ulated by cortical activity. GABAB receptor activation is involved
in numerous neuronal processes, including regulation of the in-
duction of long-term potentiation (Davies et al., 1991) and mod-
ulation of rhythmic activity in the hippocampus (Scanziani, 2000)
as well as seizure generation (Schuler et al., 2001). GABAB re-
ceptors are widely distributed in presynaptic terminals through-
out the brain (Bowery et al., 2002), and baclofen, which is known
to activate GABAB receptors, has been shown to inhibit neuro-
transmitter release of many cell types, including GABAergic in-
terneurons. However, GABAB receptors were believed to be ab-
sent in FS cells (Freund and Katona, 2007). Yet, we find that
baclofen produced the most potent inhibition of GABA release
from FS cells, andwe show that this effect ismediated byGABAB
receptors.We also observed that baclofen had a potent effect on
the TC connection with FS cells (in agreement with Porter and
Nieves, 2004), effectively excluding these cells from the feedfor-
ward inhibitory circuit. The physiological significance of the
effect of baclofen on these and other synapses remains to be in-
vestigated and, specifically, whether physiological concentra-922 Neuron 58, 911–924, June 26, 2008 ª2008 Elsevier Inc.tions of GABA activate GABAB receptors to the same extent as
baclofen.
Effects of adenosine on inhibitory synaptic transmission in
neocortex have not been previously reported. Physiologically,
adenosine concentrations in the neocortex increase during pe-
riods of activity as a result of either increases in its intracellular
levels or the enhanced corelease of ATP during synaptic trans-
mission and its subsequent conversion to adenosine by extra-
cellular ecto-50-nucleotidase (Dunwiddie and Masino, 2001).
While not as potent as the effect of muscarine or baclofen, the
effect of adenosine on perisomatic GABA release was consis-
tently observed and is potentially interesting as a homeostatic
feedback mechanism to suppress inhibition following periods
of increased activity. On the other hand, antagonizing adenosine
receptors with caffeine (Basheer et al., 2004) would regulate PC
output by reducing the inhibitory actions of adenosine.
Serotonin is an important modulatory neurotransmitter in the
brain playing a role in both normal physiology and, importantly,
in pathologies such as migraine, depression, fear and anxiety,
obsessive compulsive disorders, schizophrenia, and addiction
(Gray and Roth, 2007). It is released in neocortex by axons orig-
inating from neurons in the mesencephalic dorsal and median
raphe nuclei that preferentially target interneurons (Smiley and
Goldman-Rakic, 1996). There is a large diversity of serotonin re-
ceptors, including seven families of metabotropic receptors and
a single family of ionotropic receptors (5HT3), with 5-HT1,2,3,6 be-
ingmost abundantly present in the cortex (Raymond et al., 2001).
However, 5-HT3 receptors are not present in FS interneurons
(Morales and Bloom, 1997). Serotonin has been shown to have
diverse effects on the excitability of inhibitory neurons in neocor-
tex (Foehring et al., 2002; Xiang and Prince, 2003; Zhou and
Hablitz, 1999), but to our knowledge, it has not been previously
reported to inhibit GABA release from FS cells. It remains to be
investigated how this effect is integrated with the other cellular
effects of serotonin. The 5-HT2 receptor-mediated serotonergic
suppression of inhibition of PCs described here could have im-
portant implications to understanding the role of serotonin in
a variety of physiological and pathological states.
EXPERIMENTAL PROCEDURES
Recording of Extracellularly Evoked IPSCs
Acute brain slices (300 mm) were prepared from 16- to 21-day-old mice follow-
ing institutional animal care guidelines essentially as described previously
(Goldberg et al., 2005). Synaptic currents were recorded in whole-cell voltage
clamp of L5 PCs of mouse primary somatosensory (‘‘barrel’’) cortex visually
identified under IR-DIC by their large somata and pia-oriented apical dendrite.
During recording, slices were superfused with a solution containing (in mM)
125 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 2, MgCl2, and 10 glu-
cose (equilibrated with 95% O2/5% CO2). In some experiments, Ca
2+ was re-
duced to 1.3 mM, and Mg2+ was increased to 2.7 mM. A concentric bipolar-
stimulating electrode (125 mm in diameter; FHC) was placed laterally (100
mm) to the recording pipette within L5 (Figure 1A). IPSCs were evoked by 0.1
ms pulses, typically 20–60 mA, to keep IPSC magnitude low. Recordings
were performed at 27C–30C with patch pipettes (2.5–4.5 MU) filled with in-
tracellular solution containing (in mM) 120 CsMeSO4, 10 CsCl, 9.0 NaCl, 4.0
Mg2+-ATP, 0.3 Na+-GTP, 10 HEPES, 0.5 EGTA, and 5 lidocaine N-ethyl bro-
mide (QX-314), with pH adjusted to 7.40 with CsOH. All eIPSCs were recorded
in the presence of 10 mMCNQX and 50 mMD-APV to block excitatory synaptic
transmission. The predicted ECl under these conditions was 50 mV, and
Neuron
Modulation of Perisomatic InhibitioneIPSCs were recorded as inward currents during hyperpolarizations of the
membrane potential to80 mV (Figure 1B). Unless stated otherwise, all drugs
were locally applied through a second patch pipette located 5–10 mm from the
cell body of PC using Picospritzer III (Parker Corp) (Figure S1).
To minimize voltage-clamp errors, we used low-resistance pipettes and se-
ries resistance compensation, and we recorded at potentials close to the chlo-
ride equilibrium potential (ECl) to reduce eIPSC amplitudes. A cell was rejected
if series resistance (Rs) after break-in was >20 MU (typically, 10–15 MU), if Rs
could not be compensated to <10 MU (typically, 5–8 MU), or if Rs changed
by >20% during the experiment. Series resistance was rigorously monitored
after each evoked response. Reported values for membrane potential were
not corrected for the liquid junction potential (–12 mV). Currents were re-
corded with an Axopatch 200B amplifier (Molecular Devices), sampled at
20 kHz, low-pass filtered at 5 kHz, and digitized at 16 bit resolution (Digidata
1322A; Molecular Devices). Data analysis and the source of pharmacological
agents are described in Supplemental Data.
Paired Recordings and Morphological Reconstructions
Simultaneous whole-cell recordings were performed from INs and PC pairs
in L5 and deep L3 of primary somatosensory cortex using patch electrodes
(4–6 MU) filled with a solution containing the following (in mM): 65 KCl, 65 K-
gluconate, 10 HEPES, 0.5 EGTA, 4.0 Mg-ATP, 0.3 Na-GTP, 5 QX-314, and
1%biocytin; pH7.4,withKOH.Use of this solutionpredicts anECl$ of–20mV.
A GAD67-EGFP G42 mouse expressing EGFP in PV-expressing interneurons
(Goldberg et al., 2005) was used to aid in the identification of FS cells
(Figure S3A). A GIN mouse line expressing EGFP in a subset of somato-
statin-containing interneurons (Oliva et al., 2000) was used for the identifica-
tion of MCs. Presynaptic cells were recorded in the bridge mode of an
Axoclamp 2B amplifier (Molecular Devices), while postsynaptic cells were
recorded in voltage-clamp mode with an Axopatch 200B amplifier (Molecular
Devices). For the studies in Figure 6, we used an intracellular solution with
a predicted ECl$–70 mV (similar to that used in TC Recordings below, but
without QX-314).
After recording, slices were fixed with 4% paraformaldehyde in 0.1 M so-
dium phosphate buffer (NaPB) overnight at 4C for subsequent histological
analysis (see Supplemental Data).
Thalamocortical Recordings
Somatosensory thalamocortical slices (400 mm thick, 35 tilt from coronal
plane) were obtained from mice aged postnatal day 14–16 as previously de-
scribed (Agmon and Connors, 1991). To activate thalamic afferents, extracel-
lular stimuli were delivered to the VB through a concentric bipolar-stimulating
electrode (Figure 7A). Stimulation intensities were chosen to be just above the
threshold for EPSP detection (range 30–60 mA). Disynaptic EPSP/IPSP or
EPSC/IPSC sequences were recorded in L3/4 ECs (Vm = 45 mV); monosyn-
aptic TC EPSPs in FS INs and ECs were recorded at Vm =70 mV. Patch elec-
trodes (4–6MU) were filled with a solution containing the following (inmM): 121
K-gluconate, 9 KCl, 10 HEPES, 0.5 EGTA, 4.0Mg-ATP, and 0.3 Na-GTP, 5 QX-
314, pH 7.4. The predicted ECl under these conditions was–70 mV. Feedfor-
ward eIPSCs reversed near ECl and eEPSCs reversed at +5 mV (data not
shown).
SUPPLEMENTAL DATA
The Supplemental Data for this article, including Results, Experimental Proce-
dures, and Figures, can be found online at http://www.neuron.org/cgi/content/
full/58/6/911/DC1/.
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